<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7041086/table_2" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 2</label>
  <p>Characteristics of the infection disease at baseline. Comparison between the two infected groups</p>
 </caption>
 <thead>
  <tr>
   <th rowspan="2" colspan="1" id="0-0-B-a"/>
   <th colspan="1" rowspan="1" id="0-1-.">TOTAL</th>
   <th colspan="1" rowspan="1" id="0-2-.">VIG</th>
   <th colspan="1" rowspan="1" id="0-3-.">BIG</th>
   <th colspan="1" rowspan="1" id="0-4-.">
    <i>p</i>-value 
    <sup>b</sup>
   </th>
   <th colspan="1" rowspan="1" id="0-5-.">CG</th>
  </tr>
  <tr>
   <th colspan="1" rowspan="1" id="1-1-.">
    <i>N</i> = 63 
   </th>
   <th colspan="1" rowspan="1" id="1-2-.">
    <i>N</i> = 38 
   </th>
   <th colspan="1" rowspan="1" id="1-3-.">
    <i>N</i> = 25 
   </th>
   <th colspan="1" rowspan="1" id="1-4-."/>
   <th colspan="1" rowspan="1" id="1-5-.">
    <i>N</i> = 36 
   </th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td>Time from transplant in days, median (IQR)</td>
   <td>303 (213–560)</td>
   <td>366 (250–615)</td>
   <td>255 (198–460)</td>
   <td>0.27</td>
   <td>204 (190–232)</td>
  </tr>
  <tr>
   <td>Hospitalization, n (%)</td>
   <td>29 (46)</td>
   <td>13 (34)</td>
   <td>16 (64)</td>
   <td>0.04</td>
   <td>3 (8)</td>
  </tr>
  <tr>
   <td>Time of hospital stay in days, n (%)</td>
   <td>14 (8–22)</td>
   <td>11 (7–15)</td>
   <td>16 (12–23)</td>
   <td>0.11</td>
   <td>25 (16–26)</td>
  </tr>
  <tr>
   <td>Symptoms</td>
   <td>41 (73)</td>
   <td>23 (70)</td>
   <td>18 (78)</td>
   <td>0.69</td>
   <td>2 (6)</td>
  </tr>
  <tr>
   <td> Temperature, °C, (median, IQR)</td>
   <td>36.8 (36.4–37.0)</td>
   <td>37.0 (36.6–37.0)</td>
   <td>36.7 (36.4–36.8)</td>
   <td>0.28</td>
   <td>36.7 (36.5–36.9)</td>
  </tr>
  <tr>
   <td> Desaturation &lt; 95% AA (n, %)</td>
   <td>11 (25)</td>
   <td>3 (13)</td>
   <td>8 (40)</td>
   <td>0.08</td>
   <td>0 (0)</td>
  </tr>
  <tr>
   <td> Dyspnea (n, %)</td>
   <td>21 (43)</td>
   <td>9 (33)</td>
   <td>12 (55)</td>
   <td>0.23</td>
   <td>1 (3)</td>
  </tr>
  <tr>
   <td> Cough (n, %)</td>
   <td>28 (54)</td>
   <td>16 (52)</td>
   <td>12 (57)</td>
   <td>0.91</td>
   <td>1 (3)</td>
  </tr>
  <tr>
   <td> Sputum (n, %)</td>
   <td>23 (43)</td>
   <td>10 (32)</td>
   <td>13 (59)</td>
   <td>0.10</td>
   <td>0 (0)</td>
  </tr>
  <tr>
   <td> Coryza (n, %)</td>
   <td>12 (23)</td>
   <td>7 (21)</td>
   <td>5 (25)</td>
   <td>0.75</td>
   <td>1 (3)</td>
  </tr>
  <tr>
   <td> Auscultator abnormality (n, %)</td>
   <td>14 (28)</td>
   <td>8 (27)</td>
   <td>6 (30)</td>
   <td>1.00</td>
   <td>0 (0)</td>
  </tr>
  <tr>
   <td colspan="6">Biology</td>
  </tr>
  <tr>
   <td> Leucocytes, G/L (median, IQR)</td>
   <td>8190 (5180–1044)</td>
   <td>8100 (5950–11,070)</td>
   <td>8205 (4695–16,450)</td>
   <td>0.49</td>
   <td>8280 (6215–9910)</td>
  </tr>
  <tr>
   <td> Hemoglobin, g/dL (median, IQR)</td>
   <td>11.6 (10.7–12.3)</td>
   <td>11.5 (10.7–12.3)</td>
   <td>11.6 (10.1–12.4)</td>
   <td>0.97</td>
   <td>11.4 (10.4–12.3)</td>
  </tr>
  <tr>
   <td> Platelets, 10 
    <sup>3</sup> G/L (median, IQR) 
   </td>
   <td>250 (216–303)</td>
   <td>248 (216–321)</td>
   <td>270 (218–302)</td>
   <td>0.69</td>
   <td>261 (202–329)</td>
  </tr>
  <tr>
   <td> C-Reactive Protein, mg/L (median, IQR)</td>
   <td>6.5 (5.0–34.8)</td>
   <td>5.5 (5.0–26.3)</td>
   <td>8.5 (5.0–55.5)</td>
   <td>0.51</td>
   <td>5.0 (5.0–9.0)</td>
  </tr>
  <tr>
   <td> Creatininemia, μmol/L (median, IQR)</td>
   <td>111 (85–139)</td>
   <td>114 (85–143)</td>
   <td>105 (86–126)</td>
   <td>0.18</td>
   <td>89 (76–105)</td>
  </tr>
  <tr>
   <td> GFR, ml/min/1.73 (median, IQR)</td>
   <td>55 (44–78)</td>
   <td>56 (41–78)</td>
   <td>52 (47–74)</td>
   <td>0.93</td>
   <td>72 (57–81)</td>
  </tr>
  <tr>
   <td> Tacrolimus level, UI/L (median, IQR)</td>
   <td>8.8 (7.3–10.8)</td>
   <td>8.6 (7.1–10.5)</td>
   <td>9.4 (8.0–10.9)</td>
   <td>0.91</td>
   <td>9.2 (7.7–10.2)</td>
  </tr>
  <tr>
   <td>New infiltrate in thoracic TDM (n, %)</td>
   <td>7 (11)</td>
   <td>3 (9)</td>
   <td>4 (20)</td>
   <td>0.37</td>
   <td>3 (10)</td>
  </tr>
  <tr>
   <td>Delta FEV-1 at inclusion 
    <sup>a</sup>, ml (median, IQR) 
   </td>
   <td>−45 (− 188–68)</td>
   <td>−50 (−170–60)</td>
   <td>−260 (−410–0)</td>
   <td>0.05</td>
   <td>0 (−95–74)</td>
  </tr>
  <tr>
   <td>Antiviral therapy (n, %)</td>
   <td>21 (33)</td>
   <td>14 (37)</td>
   <td>7 (28)</td>
   <td>0.65</td>
   <td>0 (0)</td>
  </tr>
  <tr>
   <td>Antibiotic therapy (n, %)</td>
   <td>28 (44)</td>
   <td>3 (8)</td>
   <td>25 (100)</td>
   <td>&lt; 0.01</td>
   <td>0 (0)</td>
  </tr>
 </tbody>
 <tfoot>
  <p>
   <i>Abbreviations: BIG</i> bacterial infections group; 
   <i>CG</i> control group; 
   <i>GFR</i> Glomerular filtration rate; 
   <i>TDM</i> tomodensitometry; 
   <i>FEV-1</i> forced expiratory volume in 1 s; 
   <i>VIG</i> viral infections group 
  </p>
  <p>
   <sup>a</sup>
   <i>Inclusion FEV-1 - last FEV-1</i>
  </p>
  <p>
   <sup>b</sup> Comparison 
   <i>between the two infected groups, viral and bacterial infections</i>
  </p>
 </tfoot>
</table>
